GAMCO Investors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,000	Closed	-$261K	–	893
2022 Q3	$261K	Buy	+4,000	New	+$261K	﹤0.01%	774
2021 Q3	–	Sell	-3,100	Closed	-$502K	–	928
2021 Q2	$502K	Buy	+3,100	New	+$502K	﹤0.01%	760